Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2025

Jun 10, 2025

35540_dirs_2025-06-09_4df8e32e-3fd1-4170-8265-9545c28468d0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2025-05-28

Reporting Person: McPhie Karl Henry Michael (Director, Chief Executive Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Exchangeable Shares $ Common Stock (21014450) Indirect

Footnotes

F1: Represents the common stock, par value $0.001 per share (the "Common Stock") of BioSig Technologies, Inc. (the "Company") that may be issued from time to time upon the exchange, retraction or redemption of exchangeable shares of BST Sub ULC, an unlimited liability company organized under the laws of the Province of British Columbia and a wholly-owned subsidiary of the Company (the "Exchangeable Shares"). Each Exchangeable Share may be exchanged for one share of Common Stock, subject to certain exceptions. The aggregate number of Exchangeable Shares that may be exchanged for Common Stock may not exceed 19.9% of the total outstanding Common Stock until such issuance is approved by the Company's stockholders. The Exchangeable Shares do not have an expiration date.

F2: Represents shares of Common Stock held by an entity for which the Reporting Person holds voting and dispositive control.